Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival of < 10% because of diffuse symptoms leading to late-stage diagnosis. That survival could increase significantly if localized tumors could be detected early. Therefore, we used multiparametric analysis o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Mellby, Linda D., Nyberg, Andreas P., Johansen, Julia S., Wingren, Christer, Nordestgaard, Børge G., Bojesen, Stig E., Mitchell, Breeana L., Sheppard, Brett C., Sears, Rosalie C., Borrebaeck, Carl A.K.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2018
Sujets:
Biology of Neoplasia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161836/
https://ncbi.nlm.nih.gov/pubmed/30106639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.77.6658
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires